Latest Melanoma Stories
The Mesothelioma Applied Research Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the most recent
Clinical benefit fueling strong adoption in liquid biopsy market REDWOOD CITY, Calif.
OXFORD, England, April 20, 2015 /PRNewswire/ -- IMCgp100 shows partial and complete durable responses in Phase I/IIa trial in
Data from KEYNOTE-006 Study Presented at AACR Annual Meeting and Published in the New England Journal of Medicine KIRKLAND, QC, April 19, 2015 /CNW Telbec/ - Merck (NYSE: MRK),
MARLBOROUGH, Mass., April 17, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for
May is Melanoma/Skin Cancer Detection and Prevention Month HUNTSVILLE, Ala., April 16, 2015 /PRNewswire/ -- Dr.
May is Melanoma/Skin Cancer Detection and Prevention Month AUBURN, Ala., April 16, 2015 /PRNewswire/ -- Dr. Kevin T.
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
- An armed gangster.
More Images (1 images) »